Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

PHARPHAR
3 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in PHARMING GROUP NV

Yes. Citadel Advisors holds 11,972 shares of PHAR (Pharming Group), worth $162,340, as of its Q2 2026 13F filing. It increased the position by 1,783 shares (+17.5%) from Q1 2026. Citadel Advisors has held PHAR since Q4 2025, across 3 quarterly 13F filings.

Current Value

$162,340

Current Shares

11,972

Total Value Change

-$150,242

Total Shares Change

-5,718

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
11,972
+17.5%
$162,3400.0%$13.89
18
2026-Q1
Decreased
10,189
-42.4%
$169,5450.0%$15.40
0
2025-Q4
New
17,690
-
$312,5820.0%$16.81
36

Other major holders of PHAR: NewEdge Advisors, LLC, MILLENNIUM MANAGEMENT LLC, MORGAN STANLEY, JANE STREET GROUP, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used